Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter

Michael Lim, Antonio Omuro, Ingo K. Mellinghoff et al.|Neuro-Oncology|2022

Cited by 508